At a glance
- Originator Associated Biotech
- Class Antibacterials; Cephalosporins; Fluoroquinolones
- Mechanism of Action Cell wall inhibitors; DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Typhoid
Most Recent Events
- 05 Jul 2016 Chemical structure information added